Regular monitoring and patient education regarding potential adverse effects are recommended when initiating therapy with tirzepatide
(Another DPP-4 inhibitor, vildagliptin, is widely prescribed in Europe but is not available in the U.S.) These agents are also available in combination with other diabetes medications (i.e., metformin, empagliflozin, pioglitazone, dapagliflozin, ertugliflozin)
Check in with your clinician if side effects feel impactful and disruptive
Despite some limitations, FAST seems a reasonable method to identify at-risk MASH in Latin America due to the wide availability of VCTE in our region
Laser Treatments Laser therapy can effectively target stubborn pigmentation, but it comes with higher costs and a longer recovery period compared to injections
Advanced Protocol (Experienced Users) For users with multiple successful cycles and solid understanding of peptide use, advanced dosing approaches the upper limit of effective dosing before diminishing returns and increased side effects outweigh benefits